Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest.

Details

Ressource 1Download: serval:BIB_547D1AEC93C1.P001 (401.10 [Ko])
State: Public
Version: author
License: Not specified
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
Serval ID
serval:BIB_547D1AEC93C1
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest.
Journal
Journal of Antimicrobial Chemotherapy
Author(s)
Moreillon P., Bizzini A., Giddey M., Vouillamoz J., Entenza J.M.
ISSN
1460-2091 (Electronic)
ISSN-L
0305-7453
Publication state
Published
Issued date
2012
Volume
67
Number
3
Pages
652-660
Language
english
Abstract
OBJECTIVES: Laboratory detection of vancomycin-intermediate Staphylococcus aureus (VISA) and their heterogeneous VISA (hVISA) precursors is difficult. Thus, it is possible that vancomycin failures against supposedly vancomycin-susceptible S. aureus are due to undiagnosed VISA or hVISA. We tested this hypothesis in experimental endocarditis.¦METHODS: Rats with aortic valve infection due to the vancomycin-susceptible (MIC 2 mg/L), methicillin-resistant S. aureus M1V2 were treated for 2 days with doses of vancomycin that mimicked the pharmacokinetics seen in humans following intravenous administration of 1 g of the drug every 12 h. Half of the treated animals were killed 8 h after treatment arrest and half 3 days thereafter. Population analyses were done directly on vegetation homogenates or after one subculture in drug-free medium to mimic standard diagnostic procedures.¦RESULTS: Vancomycin cured 14 of 26 animals (54%; P<0.05 versus controls) after 2 days of treatment. When vegetation homogenates were plated directly on vancomycin-containing plates, 6 of 13 rats killed 8 h after treatment arrest had positive cultures, 1 of which harboured hVISA. Likewise, 6 of 13 rats killed 3 days thereafter had positive valve cultures, 5 of which harboured hVISA. However, one subculture of vegetations in drug-free broth was enough to revert all the hVISA phenotypes to the susceptible pattern of the parent. Thus, vancomycin selected for hVISA during therapy of experimental endocarditis due to vancomycin-susceptible S. aureus. These hVISA were associated with vancomycin failure. The hVISA phenotype persisted in vivo, even after vancomycin arrest, but was missed in vitro after a single passage of the vegetation homogenate on drug-free medium.¦CONCLUSIONS: hVISA might escape detection in clinical samples if they are subcultured before susceptibility tests.
Keywords
Animals, Anti-Bacterial Agents/administration & dosage, Bacteriological Techniques/methods, Disease Models, Animal, Endocarditis, Bacterial/drug therapy, Endocarditis, Bacterial/microbiology, Injections, Intravenous, Rats, Selection, Genetic, Sensitivity and Specificity, Staphylococcal Infections/drug therapy, Staphylococcal Infections/microbiology, Staphylococcus aureus/drug effects, Staphylococcus aureus/isolation & purification, Vancomycin/administration & dosage, Vancomycin Resistance
Pubmed
Web of science
Open Access
Yes
Create date
01/04/2012 14:55
Last modification date
25/09/2019 7:09
Usage data